Protozoa in respiratory pathology: A review

European Respiratory Journal

Volumn 32, Issue 5, 2008, Pages 1354-1370

  Martinez Giron R ^a,d   Esteban, J G ^b   Ribas, A ^a   Doganci, L ^c  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^d NONE   (Spain)

Author keywords

Parasitic pulmonary diseases; Protozoa; Protozoal respiratory pathology

Indexed keywords

ALBENDAZOLE; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIPROTOZOAL AGENT; ATOVAQUONE PLUS PROGUANIL; AZITHROMYCIN; BENZNIDAZOLE; CHLOROQUINE; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; FUMAGALINE; MEFLOQUINE; METRONIDAZOLE; MILTEFOSINE; NIFURTIMOX; NITAZOXANIDE; PAROMOMYCIN; PYRIMETHAMINE; PYRIMETHAMINE SULFADIAZINE; QUINIDINE GLUCONATE; QUININE; QUININE SULFATE; STIBOGLUCONATE SODIUM; SULFADIAZINE; TETRACYCLINE; TINIDAZOLE; UNCLASSIFIED DRUG;

ACANTHAMOEBA; ACQUIRED IMMUNE DEFICIENCY SYNDROME; APICOMPLEXA; BABESIA DIVERGENS; BABESIA MICROTI; BABESIOSIS; BALAMUTHIA; BALANTIDIUM; CHAGAS DISEASE; CILIATE; CONTINUOUS INFUSION; CRYPTOSPORIDIUM HOMINIS; CRYPTOSPORIDIUM PARVUM; CYCLOSPORA CAYETANENSIS; DRUG SUBSTITUTION; ENCEPHALITOZOON; ENTAMOEBA HISTOLYTICA; ENTEROCYTOZOON; GENUS; HEMATOLOGIC DISEASE; HUMAN; IMMIGRATION; IMMUNITY; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIA TROPICA; LOADING DRUG DOSE; MALARIA; NAEGLERIA FOWLERI; NONHUMAN; PHYLUM; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTOZOAL INFECTION; PROTOZOON; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTION; REVIEW; SARCOMASTIGOPHORA; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT DURATION; TRICHOMONAS VAGINALIS; TRYPANOSOMA CRUZI; TRYPANOSOMA GAMBIENSE; TRYPANOSOMA RHODESIENSE; ZOONOSIS;

ANIMALS; ANTIPROTOZOAL AGENTS; CRYPTOSPORIDIUM; ENTAMOEBA HISTOLYTICA; HUMANS; IMMUNE SYSTEM; LEISHMANIA; PROTOZOA; PULMONARY MEDICINE; RESPIRATORY TRACT INFECTIONS; TRYPANOSOMA;

EID: 58849155549     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00022008     Document Type: Review

References (216)

1. Cavalier-Smith T. Kingdom protozoa and its 18 phyla. Microbiol Rev 1993; 57: 953-994.
2. Levine ND, Corliss JO, Cox FE, et al. A newly revised classification of the protozoa. J Protozool 1980; 27: 37-58.
3. Lednicky JA, Rayner JO. Uncommon respiratory pathogens. Curr Opin Pulm Med 2006; 12: 235-239.
4. Vijayan VK. How to diagnose and manage common parasitic pneumonias. Curr Opin Pulm Med 2007; 13: 218-224.
5. Drugs for Parasitic Infections. Treatment Guidelines from The Medical Letter. Vol. 5. New Rochelle, The Medical Letter, 2007. pp. 1-15.
6. Ibarra-Pérez C. Thoracic complications of amoebic abscess of the liver: report of 501 cases. Chest 1981; 79: 672-677.
7. Roberts PP. Parasitic infections of the pleural space. Semin Respir Infect 1988; 3: 362-382.
8. Lyche KD, Jensen WA. Pleuropulmonary amebiasis. Semin Respir Infect 1997; 12: 106-112.
9. García Uribe JA, Padua Gabriel A, Quintana O, García Vázquez A, de la Escosura G. 3 cases of hematogenous lung abscess of amebic origin. Rev Invest Clin 1991; 43; 264-268.
10. Lichtenstein A, Kondo AT, Visvesvara GS, et al. Pulmonary amoebiasis presenting as superior vena cava syndrome. Thorax 2005; 60: 350-352.
11. Thorsen S, Ronne-Rasmussen J, Petersen E, Isager H, Seefeldt T, Mathiesen L. Extra-intestinal amebiasis: clinical presentation in a non-endemic setting. Scand J Infect Dis 1993; 25: 747-750.
12. Shamsuzzaman SM, Hashiguchi Y. Thoracic amebiasis. Clin Chest Med 2002; 23: 479-492.
13. Mandal SK, Chakraborty PP, Bhattacharjee R, Chowdhury SR, Majumdar S. An unusual cause of dyspnoea complicating right upper abdominal swelling. World J Gastroenterol 2006; 12: 4109-4111.
14. Mbaye PS, Koffi N, Camara P, Burgel PR, Hovette P, Klotz F. Pleuropulmonary manifestations of amebiasis. Rev Pneumol Clin 1998; 54: 346-352.
15. Landay MJ, Setiawan H, Hirsch G, Christensen EE, Conrad MR. Hepatic and thoracic amebiasis. Am J Roentgenol 1980; 135: 449-454.
16. Huch Boni RA, Peter J, Marincek B. Amebic abscess of the liver manifested by "hemoptysis": US, CT and MRI findings. Abdom Imaging 1995; 20: 214-216.
17. Blayac PM, Maubon A, Ferru JM, Berges P, Reynaud D, Rouanet JP. Hepatic abscess with hepato-bronchial fistula. J Radiol 1997; 78: 469-471.
18. Walsh TJ, Berkman W, Brown NL, Padleckas R, Jao W, Mond E. Cytopathologic diagnosis of extracolonic amebiasis. Acta Cytol 1983; 27: 671-675.
19. Bhambhani S, Kashyap V. Amoebiasis: diagnosis by aspiration and exfoliative cytology. Cytopathology 2001; 12: 329-333.
20. Kennedy D, Sharma OP. Hemoptysis in a 49-year-old man. An unusual presentation of a sporadic disease. Chest 1990; 98: 1275-1278.
21. Hara A, Hirose Y, Mori H, Iwao H, Kato T, Kusuhara Y. Cytopathologic and genetic diagnosis of pulmonary amebiasis: a case report. Acta Cytol 2004; 48: 547-550.
22. Dao AH, Robinson DP, Wong SW. Frequency of Entamoeba gingivalis in human gingival scrapings. Am J Clin Pathol 1983; 80: 380-383.
23. Rosenberg M, Rachman R. Entamoeba gingivalis in sputum. Its distinction from Entamoeba histolytica. Acta Cytol 1970; 14: 361-362.
24. Dao AH. Entamoeba gingivalis in sputum smears. Acta Cytol 1985; 29: 632-633.
25. Schuster FL, Visvesvara GS. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int J Parasitol 2004; 34: 1001-1027.
26. Winiecka-Krusnell J, Linder E. Bacterial infections of free-living amoebae. Res Microbiol 2001; 152: 613-619.
27. Greub G, Raoult D. Microorganisms resistant to free-living amoebae. Clin Microbiol Rev 2004; 17: 413-433.
28. Horn M, Wagner M. Bacterial endosymbionts of free-living amoebae. J Eukaryot Microbiol 2004; 51: 509-514.
29. Hilbi H, Weber SS, Ragaz C, Nyfeler Y, Urwyler S. Environmental predators as models for bacterial pathogenesis. Environ Microbiol 2007; 9: 563-575.
30. Shadrach WS, Rydzewski K, Laube U, et al. Balamuthia mandrillaris, free-living amoeba and opportunistic agent of encephalitis, is a potential host for Legionella pneumophila bacteria. Appl Environ Microbiol 2005; 71: 2244-2249.
31. Albert-Weissenberger C, Cazalet C, Buchrieser C. Legionella pneumophila - a human pathogen that co-evolved with fresh water protozoa. Cell Mol Life Sci 2006; 64: 432-448.
32. Whan L, Grant IR, Rowe MT. Interaction between Mycobacterium avium subsp. paratuberculosis and environmental protozoa. BMC Microbiol 2006; 6: 63.
33. Thomas V, McDonnell G. Relationship between mycobacteria and amoebae: ecological and epidemiological concerns. Lett Appl Microbiol 2007; 45: 349-357.
34. Essig A, Heinemann M, Simnacher U, Marre R. Infection of Acanthamoeba castellanii by Chlamydia pneumoniae. Appl Environ Microbiol 1997; 63: 1396-1399.
35. Abd H, Johansson T, Golovliov I, Sandström G, Forsman M. Survival and growth of Fracisella tularensis in Acanthamoeba castellanii. Appl Environ Microbiol 2003; 69: 600-606.
36. Berger P, Papazian L, Drancourt M, La Scola B, Auffray JP, Raoult D. Ameba-associated microorganisms and diagnosis of nosocomial pneumonia. Emerg Infect Dis 2006; 12: 248-255.
37. Martinez AJ, Markowitz SM, Duma RJ. Experimental pneumonitis and encephalitis caused by acanthamoeba in mice: pathogenesis and ultrastructural features. J Infect Dis 1975; 131: 692-699.
38. Willaert E, Stevens AR. Experimental pneumonitis induced by Naegleria fowleri in mice. Trans R Soc Trop Med Hyg 1980; 74: 779-783.
39. Westmoreland SV, Rosen J, MacKey J, et al. Necrotizing meningoencephalitis and pneumonitis in a simian immunodeficiency virus-infected rhesus macaque due to Acanthamoeba. Vet Pathol 2004; 41: 398-404.
40. Khan M, La Scola B, Lepidi H, Raoult D. Pneumonia in mice inoculated experimentally with Acanthamoeba polyphaga mimivirus. Microb Pathog 2007; 42: 56-61.
41. Yagi S, Booton GC, Visvesvara GS, Schuster FL. Detection of Balamuthia mitochondrial 16S rRNA gene DNA in clinical specimens by PCR. J Clin Microbiol 2005; 43: 3192-3197.
42. Mutreja D, Jalpota Y, Madan R, Tewari V. Disseminated acanthamoeba infection in a renal transplant recipient: a case report. Indian J Pathol Microbiol 2007; 50: 346-348.
43. Visvesvara GS, Moura H, Schuster FL. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Med Microbiol 2007; 50: 1-26.
44. Newsome AL, Curtis FT, Culbertson CG, Allen SD. Identification of acanthamoeba in bronchoalveolar lavage specimens. Diagn Cytopathol 1992; 8: 231-234.
45. Shin HJ, Im K. Pathogenic free-living amoebae in Korea. Korean J Parasitol 2004; 42: 93-119.
46. Siripanth C, Punpoowong B, Riganti M. Early detection and identification of amphizoic amoebae from nasal exudates of a symptomatic case. J Med Assoc Thai 2005; 88: 545-549.
47. McLaren LC, Davis LE, Healy GR, James CG. Isolation of Trichomonas vaginalis from the respiratory tract of infants with respiratory disease. Pediatrics 1983; 71: 888-890.
48. Hiemstra I, Van Bel F, Berger HM. Can Trichomonas vaginalis cause pneumonia in newborn babies? Br Med J 1984; 289: 355-356.
49. Duboucher C, Noël C, Durand-Joly I, et al. Pulmonary coinfection by Trichomonas vaginalis and Pneumocystis sp. as a novel manifestation of AIDS. Hum Pathol 2003; 34: 508-511.
50. Duboucher C, Gerbod D, Noel C, et al. Frequency of trichomonads as coinfecting agents in Pneumocystis pneumonia. Acta Cytol 2005; 49: 273-277.
51. Duboucher C, Caby S, Pierce RJ, Capron M, Dei-Cas E, Viscogliosi E. Trichomonads as superinfecting agents in Pneumocystis pneumonia and acute respiratory distress syndrome. J Eukaryot Microbiol 2006; 53: Suppl. 1, S95-S97.
52. Duboucher C, Barbier C, Beltramini A, et al. Pulmonary superinfection by Trichomonads in the course of acute respiratory distress syndrome. Lung 2007; 185: 295-301.
53. Temesvári P, Kerekes A, Tege A, Szarka K. Demonstration of Trichomonas vaginalis in tracheal aspirates in infants with early respiratory failure. J Matern Fetal Neonatal Med 2002; 11: 347-349.
54. Smith LM, Wang M, Zangwill K, Yeh S. Trichomonas vaginalis infection in a premature newborn. J Perinatol 2002; 22: 502-503.
55. Carter JE, Whithaus KC. Neonatal respiratory tract involvement by Trichomonas vaginalis: a case report and review of the literature. Am J Trop Med Hyg 2008; 78: 17-19.
56. Hoffman DJ, Brown GD, Wirth FH, Gebert BS, Bailey CL, Anday EK. Urinary tract infection with Trichomonas vaginalis in a premature infant and the development of chronic lung disease. J Perinatol 2003; 23: 59-61.
57. Hersh SM. Pulmonary trichomoniasis and Trichomonas tenax. J Med Microbiol 1985; 20: 1-10.
58. Shiota T, Arizono N, Morimoto T, Shimatsu A, Nakao K. Trichomonas tenax empyema in an immunocompromised patient with advanced cancer. Parasite 1998; 5: 375-377.
59. Ha GY, Kim MY, Kim SS, Kim SJ, Lee YH. A case of pulmonary trichomoniasis. Korean J Clin Pathol 2001; 21: 485-489.
60. Osborne PT, Giltman LI, Uthman EO. Trichomonads in the respiratory tract. A case report and literature review. Acta Cytol 1984; 28: 136-138.
61. Radosavljevic-Asic G, Jovanovic D, Radovanovic D, Tucakovic M. Trichomonas in pleural effusion. Eur Respir J 1994; 7: 1906-1908.
62. Lewis KL, Doherty DE, Ribes J, Seabolt JP, Bensadoun ES. Empyema caused by trichomonas. Chest 2003; 123: 291-292.
63. Wang HK, Jerng JS, Su KE, Chang SC, Yang PC. Trichomonas empyema with respiratory failure. Am J Trop Med Hyg 2006; 75: 1234-1236.
64. El Kamel A, Rouetbi N, Chakroun M, Battikh M. Pulmonary eosinophilia due to Trichomonas tenax. Thorax 1996; 51: 554-555.
65. Mahmoud MS, Rahman GA. Pulmonary trichomoniasis: improved diagnosis by using polymerase chain reaction targeting Trichomonas tenax 18S rRNA gene in sputum specimens. J Egypt Soc Parasitol 2004; 34: 197-211.
66. Mallat H, Podglajen I, Lavarde V, Mainardi JL, Frappier J, Cornet M. Molecular characterization of Trichomonas tenax causing pulmonary infection. J Clin Microbiol 2004; 42: 3886-3887.
67. Memik F. Trichomonads in pleural effusion. JAMA 1968; 204: 1145-1146.
68. Jongwutiwes S, Silachamroon U, Putaporntip C. Pentatrichomonas hominis in empyema thoracics. Trans R Soc Trop Med Hyg 2000; 94: 185-186.
69. Kutisova K, Kulda J, Cepicka I, et al. Tetratrichomonads from the oral cavity and respiratory tract of humans. Parasitology 2005; 131: 309-319.
70. Duboucher C, Caby S, Dufernez F, et al. Molecular identification of Tritrichomonas foetus-like organisms as coinfecting agents of human Pneumocystis pneumonia. J Clin Microbiol 2006; 44: 1165-1168.
71. Zhou YP, Zhu XJ, Li M, Liu H, Chen YS. [Clinical analysis of bronchopulmonary infection with hypermastigotes: a report of two cases and review of the Chinese literature]. Zhonghua Jie He He Hu Xi Za Zhi 2006; 29: 23-25.
72. Nie XM, Yao XP, Huang Y, Zhou DY, Chang ZS, Li Q. [Amiodarone pneumonitis with Hypermastigote lung infection: a case report and review of the literatures]. Zhonghua Jie He He Hu Xi Za Zhi 2006; 29: 310-312.
73. Wang Y, Tang Z, Ji S, et al. Pulmonary Lophomonas blattarum infection in patients with kidney allograft transplantation. Transpl Int 2006; 19: 1006-1013.
74. Ribas A, Mosquera JA. Ameboflagellates in bronchial asthma. Acta Cytol 1998; 42: 685-690.
75. Ribas A, Jou C, Escobar J. Ciliocythophthoria and ameboflagellates. Acta Cytol 2003; 47: 705-708.
76. Ribas A, Martínez-Girón R, Sánchez-del-Río J, González Alonso D. Protozoal forms in the sputum of immunocompromized patients. Scand J Infect Dis 2005; 37: 205-210.
77. Ribas A, Martínez-Girón R, Ponte-Mittelbrum C, Alonso-Cuervo R, Iglesias-Llaca F. Immunosupression, flagellated protozoa in the human airways and metronidazole: observations on the state of the art. Transpl Int 2007; 20: 811-812.
78. Ribas A, Martínez-Girón R. Protozoal forms in house-dust mites and respiratory allergy. Allergy Asthma Proc 2006; 27: 347-349.
79. Martínez-Girón R, Ribas A. Asthma, cockroaches, and protozoal forms: chance or not chance? Ann Allergy Asthma Immunol 2006; 97: 818-819.
80. Martínez-Girón R, Ribas A, Astudillo-González A. Flagellated protozoa in cockroaches and sputum: the unhygienic connection? Allergy Asthma Proc 2007; 28: 608-609.
81. Herwaldt BL. Leishmaniasis. Lancet 1999; 354: 1191-1199.
82. Matheron S, Cabié A, Parquin F, et al. Visceral leishmaniasis and HIV infection: unusual presentation with pleuropulmonary involvement, and effect of secondary prophylaxis. AIDS 1992; 6: 238-240.
83. Alvar J, Cañavate C, Gutiérrez-Solar B, et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 1997; 10: 298-319.
84. Goncalves R, Tafuri WL, de Melo MN, Raso P, Tafuri WL. Chronic interstitial pneumonitis in dogs naturally infected with Leishmania (Leishmania) chagasi: a histopathological and morphometric study. Rev Inst Med Trop Sao Paulo 2003; 45: 153-158.
85. Duarte MI, da Matta VL, Corbett CE, Laurenti MD, Chebabo R, Goto H. Interstitial pneumonitis in human visceral leishmaniasis. Trans R Soc Trop Med Hyg 1989; 83: 73-76.
86. Marshall BG, Kropf P, Murray K, et al. Bronchopulmonary and mediastinal leishmaniasis: an unusual clinical presentation of Leishmania donovani infection. Clin Infect Dis 2000; 30: 764-769.
87. Chenoweth CE, Singal S, Pearson RD, Betts RF, Markovitz DM. Acquired immunodeficiency syndrome-related visceral leishmaniasis presenting in a pleural effusion. Chest 1993; 103: 648-649.
88. Muñoz-Rodríguez FJ, Padró S, Pastor P, et al. Pleural and peritoneal leishmaniasis in an AIDS patient. Eur J Clin Microbiol Infect Dis 1997; 16: 246-248.
89. Herrejón A, Cervera A, Maciá M, Ferrer R, Blanquer R. Adenoma bronquioloalveolar asociado a bronquiolitis obliterante y leishmaniasis pulmonar en el sida [Bronchoalveolar adenoma associated with bronchiolitis obliterans and leishmaniasis with lung involvement in acquired immunodeficiency syndrome]. Arch Bronconeumol 2005; 41: 233-235.
90. Rosenthal E, Marty P, Pesce A. Leishmania in bronchoalveolar lavage. Ann Intern Med 1991; 114: 1064-1065.
91. Jopikii L, Salmela K, Saha H, et al. Leishmaniasis diagnosed from bronchoalveolar lavage. Scand J Infect Dis 1992; 24: 677-681.
92. González-Anglada MI, Peñ a JM, Barbado FJ, et al. Two cases of laryngeal leishmaniasis in patients infected with HIV. Eur J Clin Microbiol Infect Dis 1994; 13: 509-511.
93. Cánovas DL, Carbonell J, Torres J, Altés J, Buades J. Laryngeal leishmaniasis as initial opportunistic disease in HIV infection. J Laryngol Otol 1994; 108: 1089-1092.
94. Navarro Cunchillos M, Villanueva Marcos JL, Torre-Cisneros J, Ostos Aumente P, López-Rubio F, López Villarejo P. Isolated laryngeal leishmaniasis in an immunocompetent patient: successful treatment with surgery. J Laryngol Otol 1994; 108: 249-251.
95. Grant A, Sparaggs PD, Grant HR, Bryceson AD. Laryngeal leishmaniasis. J Laryngol Otol 1994; 1086-1088.
96. Guddo F, Gallo E, Cillari E, et al. Detection of leishmania infantum kinetoplast DNA in laryngeal tissue from an immunocompetent patient. Hum Pathol 2005; 36: 1140-1142.
97. Sundar S, Rai M. Treatment of visceral leishmaniasis. Expert Opin Pharmacother 2005; 6: 2821-2829.
98. Lemle A. Chagas' disease. Chest 1999; 115: 906.
99. Camara EJN, Lima JAC, Oliveira GB, Machado AS. Pulmonary findings in patients with chagasic mega-esophagus. Chest 1983; 83: 87-91.
100. Melnikov VG, Fierro Velasco F, Espinoza Gómez F, Guzmán Rodríguez F, Dobrovinskaya OR. Pathologic changes in lungs caused by Mexican isolates of Trypanosoma cruzi in the acute phase of infection in mice. Am J Trop Med Hyg 2005; 73: 301-306.
101. Bittencourt AL, Rodrigues de Freitas LA, Galvao de Araujo MO, Jácomo K. Pneumonitis in congenital Chagas' disease. A study of ten cases. Am J Trop Med Hyg 1981; 30: 38-42.
102. Mansfield LS, Gajadhar AA. Cyclospora cayetanensis, a food- and waterborne coccidian parasite. Vet Parasitol 2004; 126: 73-90.
103. Di Gliullo AB, Cribari MS, Bava AJ, Cicconetti JS, Collazos R. Cyclospora cayetanensis in sputum and stool samples. Rev Inst Med Trop Sao Paulo 2000; 42: 115-117.
104. Hussein EM, Abdul-Manaem AH, el-Attary SL. Cyclospora cayetanensis oocysts in sputum of a patient with active pulmonary tuberculosis, case report in Ismailia, Egypt. J Egypt Soc Parasitol 2005; 35: 787-793.
105. Xiao L, Fayer R, Ryan U, Upton SJ. Cryptosporidium taxonomy: recent advances and implications for public health. Clin Microbiol Rev 2004; 17: 72-97.
106. Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev 2002; 15: 145-154.
107. Forgacs P, Tarshis A, Ma P, et al. Intestinal and bronchial cryptosporidiosis in an immunodeficient homosexual man. Ann Intern Med 1983; 99: 793-794.
108. Brady EM, Margolis ML, Korzeniowski OM. Pulmonary cryptosporidiosis in acquired immune deficiency syndrome. JAMA 1984; 252: 89-90.
109. Ma P, Villanueva TG, Kaufmann D, Gillooley JF. Respiratory cryptosporidiosis in acquired immune deficiency syndrome. JAMA 1984; 252: 1298-1301.
110. Hojlyng N, Jensen BN. Respiratory cryptosporidiosis in HIV-positive patients. Lancet 1988; 1: 590-591.
111. Moore JA, Frenkel JK. Respiratory and enteric cryptosporidiosis in humans. Arch Pathol Lab Med 1991; 115: 1160-1162.
112. Brea Hernando AJ, Bandres Franco E, Mosquera Lozano JD, Lantero Benedito M, Ezquerra Lezcano M. [Pulmonary cryptosporidiosis and AIDS. Presentation of a case and review of the literature]. An Med Interna 1993; 10: 232-236.
113. López-Vélez R, Tarazona R, Garcia Camacho A, et al. Intestinal and extraintestinal cryptosporidiosis in AIDS patients. Eur J Clin Microbiol Infect Dis 1995; 14: 677-681.
114. Meynard JL, Meyohas MC, Binet D, Chouaid C, Frottier J. Pulmonary cryptosporidiosis in the acquired immunodeficiency syndrome. Infection 1996; 24: 328-331.
115. Clavel A, Arnal AC, Sanchez EC, et al. Respiratory cryptosporidiosis: case series and review of the literature. Infection 1996; 24: 341-346.
116. Pellicelli AM, Palmieri F, Spinazzola F, et al. Pulmonary cryptosporidiosis in patients with acquired immunodeficiency syndrome. Minerva Med 1998; 89: 173-175.
117. Travis WD, Schmidt K, MacLowry JD, Masur H, Condron KS, Fojo AT. Respiratory cryptosporidiosis in a patient with malignant lymphoma. Report of a case and review of the literature. Arch Pathol Lab Med 1990; 114: 519-522.
118. Kibbler CC, Smith A, Hamilton-Dutoit SJ, Milburn H, Pattinson JK, Prentice HG. Pulmonary cryptosporidiosis occurring in a bone marrow transplant patient. Scand J Infect Dis 1987; 19: 581-584.
119. Gentile G, Venditti M, Micozzi A, et al. Cryptosporidiosis in patients with hematologic malignancies. Rev Infect Dis 1991; 13: 842-846.
120. Gentile G, Baldassari L, Caprioli A, et al. Colonic vascular invasion as a possible route of extraintestinal cryptosporidiosis. Am J Med 1987; 82: 574-575.
121. Roussel F, Lemeteil D, Favennec L, Tayot J, Ballet JJ, Brasseur P. Respiratory tract cryptosporidiosis in immunosuppressed rat is associated with an epithelial metaplasia. Parasite 1995; 2: 85-87.
122. Lanzarini P, Gatti S, Bruno A, Corona S, Scaglia M. Experimental respiratory cryptosporidiosis in immunosupressed rats: a light and electron microscopy study. Parasite 1996; 6: 217-222.
123. Yanai T, Chalifoux LV, Mansfield KG, Lackner AA, Simon MA. Pulmonary cryptosporidiosis in simian immunodeficiency virus-infected rhesus macaques. Vet Pathol 2000; 37: 472-475.
124. Miller RA, Wasserheit JN, Kirihara J, Coyle MB. Detection of cryptosporidium oocysts in sputum during screening for mycobacteria. J Clin Microbiol 1984; 20: 1192-1193.
125. Dupont C, Bougnoux ME, Turner L, Rouveix E, Dorra M. Microbiological findings about pulmonary cryptosporidiosis in two AIDS patients. J Clin Microbiol 1996; 34: 227-229.
126. Mercado R, Buck GA, Manque PA, Ozaki LS. Cryptosporidium hominis infection of the human respiratory tract. Emerg Infect Dis 2007; 13: 462-464.
127. Palmieri F, Cicalini S, Froio N, et al. Pulmonary cryptosporidiosis in an AIDS patient: successful treatment with paromomycin plus azithromicyn. Int J STD AIDS 2005; 16: 515-517.
128. Mohri H, Fujita H, Asakura Y, et al. Case report: inhalation therapy of paromomycin is effective for respiratory infection and hypoxia by cryptosporidium with AIDS. Am J Med Sci 1995; 309: 60-62.
129. Leal FE, Cavazzana CL, de Andrade HF Jr, Galisteo AJ Jr, de Mendoza JS, Kallas EG. Toxoplasma gongii pneumonia in immunocompetent subjects: case report and review. Clin Infect Dis 2007; 44: 62-66.
130. Pomeroy C, Filice GA. Pulmonary toxoplasmosis: a review. Clin Infect Dis 1992; 14: 863-870.
131. Hofman P, Bernard E, Michiels JF, Thyss A, Le Fichoux Y, Loubiere R. Extracerebral toxoplasmosis in the acquired immunodeficiency syndrome (AIDS). Pathol Res Pract 1993; 189: 894-901.
132. Mendelson MH, Finkel LJ, Meyers BR, Lieberman JP, Hirschman SZ. Pulmonary toxoplasmosis in AIDS. Scand J Infect Dis 1987; 19: 703-706.
133. Oksenhendler E, Cadranel J, Sarfati C, et al. Toxoplasma gondii pneumonia in patients with the acquired immunodefiency syndrome. Am J Med 1990; 88: 18-21.
134. Schnapp LM, Geaghan SM, Campagna A, et al. Toxoplasma gondii pneumonitis in patients with the human immunodeficiency virus. Arch Intern Med 1992; 152: 1073-1077.
135. Nash G, Kerschmann RL, Herndier B, Dubey JP. The pathological manifestations of pulmonary toxoplasmosis in the acquired immunodeficiency syndrome. Hum Pathol 1994; 25: 652-658.
136. Rabaud C, May T, Lucet JC, Leport C, Ambroise-Thomas P, Canton P. Pulmonary toxoplasmosis in patients infected with human immunodeficiency virus: a French National Survey. Clin Infect Dis 1996; 23: 1249-1254.
137. Asensi V, Cartón JA, Maradona JA, et al. [Pulmonary toxoplasmosis. Study of 4 cases and review of the literature]. Enferm Infecc Microbiol Clin 1993; 11: 195-198.
138. Singh N, Gayowski T, Marino IR. Toxoplasma gondii pneumonitis in a liver transplant recipient: implications for diagnosis. Liver Transpl Surg 1996; 2: 299-300.
139. Saad R, Vincent JF, Cimon B, et al. Pulmonary toxoplasmosis after allogenic bone marrow transplantation: case report and review. Bone Marrow Transplant 1996; 18: 211-212.
140. Sing A, Leitritz L, Roggenkamp A, et al. Pulmonary toxoplasmosis in bone marrow transplant recipients: report of two cases and review. Clin Infect Dis 1999; 29: 429-433.
141. Munir A, Zaman M, Eltorky M. Toxoplasma gondii pneumonia in a pancreas transplant patient. South Med J 2000; 93: 614-617.
142. Mele A, Paterson PJ, Prentice HG, Leoni P, Kibbler CC. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant 2002; 29: 691-698.
143. Fricker-Hidalgo H, Brion JP, Durand M, Chavanon O, Brenier-Pinchart MP, Pelloux H. Disseminated toxoplasmosis with pulmonary involvement after heart transplantation. Transpl Infect Dis 2005; 7: 38-40.
144. Evans TG, Schwartzman JD. Pulmonary toxoplasmosis. Semin Respir Infect 1991; 6: 51-57.
145. Mariuz P, Bosler EM, Luft BJ. Toxoplasma pneumonia. Semin Respir Infect 1997; 12: 40-43.
146. Filice GA, Clabots CR, Riciputi PE, Goñi-Laguarda O, Pomeroy C. Changes in cytokine levels during reactivation of Toxoplasma gondii infection in lungs. Infect Immun 1999; 67: 2082-2089.
147. Gandhi S, Lyubsky S, Jimenez-Lucho V. Adult respiratory distress syndrome associated with disseminated toxoplasmosis. Clin Infect Dis 1994; 19: 169-171.
148. Ortonne N, Ribaud P, Meignin V, et al. Toxoplasmic pneumonitis leading to fatal acute respiratory distress syndrome after engraftment in three bone marrow transplant recipients. Transplantation 2001; 72: 1838-1840.
149. Charles PE, Doise JM, Quenot JP, et al. An unusual cause of acute respiratory distress in a patient with AIDS: primary infection with Toxoplasma gondii. Scand J Infect Dis 2003; 35: 901-902.
150. Goodman PC, Schnapp LM. Pulmonary toxoplasmosis in AIDS. Radiology 1992; 184: 791-793.
151. Dawis MA, Bottone EJ, Vlachos A, Burroughs MH. Unsuspected Toxoplasma gondii empyema in a bone marrow transplant recipient. Clin Infect Dis 2002; 34: 37-39.
152. Collet G, Marty P, Le Fichoux Y, et al. Pleural effusion as the first manifestation of pulmonary toxoplasmosis in a bone marrow transplant recipient. Acta Cytol 2004; 48: 114-116.
153. Jacobs F, Depierreux M, Goldman M, et al. Role of bronchoalveolar lavage in diagnosis of disseminated toxoplasmosis. Rev Infect Dis 1991; 13: 637-641.
154. Bottone EJ. Diagnosis of acute pulmonary toxoplasmosis by visualization of invasive and intracellular tachyzoites in Giemsa-stained smears of bronchoalveolar lavage fluid. J Clin Microbiol 1991; 29: 2626-2627.
155. Sternberg RI, Baughman RP, Dohn MN, First MR. Utility of bronchoalveolar lavage in assessing pneumonia in immunosuppressed renal transplant recipients. Am J Med 1993; 95: 358-364.
156. Gordon SM, Gal AA, Hertzler GL, Bryan JA, Perlino C, Kanter KR. Diagnosis of pulmonary toxoplasmosis by bronchoalveolar lavage in cardiac transplant recipients. Diagn Cytopathol 1993; 9: 650-654.
157. Laibe S, Ranque S, Curtillet C, Faraut F, Dumon H, Franck J. Timely diagnosis of disseminated toxoplasmosis by sputum examination. J Clin Microbiol 2006; 44: 646-648.
158. Bretagne S, Costa JM, Fleury-Feith J, Poron F, Dubreuil-Lemaire ML, Vidaud M. Quantitative competitive PCR with bronchoalveolar lavage fluid for diagnosis of toxoplasmosis in AIDS patients. J Clin Microbiol 1995; 33: 1662-1664.
159. Petersen E, Edvinsson B, Lundgren B, Benfield T, Evengard B. Diagnosis of pulmonary infection with Toxoplasma gondii in immunocompromised HIV positive patients by real-time PCR. Eur J Clin Microbiol Infect Dis 2006; 25: 401-404.
160. Campagna AC. Pulmonary toxoplasmosis. Semin Respir Infect 1997; 12: 98-105.
161. Jelinek T, Schulte C, Behrens R, et al. Imported falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clin Infect Dis 2002; 34: 572-576.
162. Pérez-Arellano JL, Carranza C. Infecciones respiratorias importadas: nuevos retos y amenazas [Imported respiratory infections: new challenges and threats]. Arch Bronconeumol 2003; 39: 289-291.
163. Anstey NM, Jacups SP, Cain T, et al. Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough, small airways obstruction, impaired gas transfer, and increased pulmonary phagocytic activity. J Infect Dis 2002; 185: 1326-1334.
164. Hovette P, Camara P, Burgel PR, Mbaye PS, Sane M, Klotz F. Pulmonary manifestations associated with malaria. Rev Pneumol Clin 1998; 54: 340-345.
165. Taylor WR, White NJ. Malaria and the lung. Clin Chest Med 2002; 23: 457-468.
166. Illamperuma C, Allen BL. Pulmonary edema due to Plasmodium vivax malaria in an American missionary. Infection 2007; 35: 374-376.
167. Taylor WR, Cañon V, White NJ. Pulmonary manifestations of malaria: recognition and management. Treat Respir Med 2006; 5: 419-428.
168. Muanza K, Gay F, Behr C, Schert A. Primary culture of human lung microvessel endothelial cells: a useful in vitro model for studying Plasmodium falciparum-infected erythrocyte cytoadherence. Res Immunol 1996; 147: 149-163.
169. Traoré B, Muanza K, Looareesuwan S, et al. Cytoadherence characteristics of Plasmodium falciparum isolates in Thailand using an in vitro human lung endothelial cells model. Am J Trop Med Hyg 2000; 62: 38-44.
170. Gachot B, Wolff M, Nissack G, Veber B, Vachon F. Acute lung injury complicating imported Plasmodium falciparum malaria. Chest 1995; 108: 746-749.
171. Asiedu DK, Sherman CB. Adult respiratory distress syndrome complicating Plasmodium falciparum malaria. Heart Lung 2000; 29: 294-297.
172. Maguire GP, Handojo T, Pain MC, et al. Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in Papua, Indonesia. J Infect Dis 2005; 192: 1966-1974.
173. Carlini ME, White AC Jr, Atmar RL. Vivax malaria complicated by adult respiratory distress syndrome. Clin Infect Dis 1999; 28: 1182-1183.
174. Tanios MA, Kogelman L, McGovern B, Hassoun PM. Acute respiratory distress syndrome complicating Plasmodium vivax malaria. Crit Care Med 2001; 29: 665-667.
175. Habib AG, Singh KS. Respiratory distress in nonimmune adults with imported malaria. Infection 2004; 32: 356-359.
176. Lomar AV, Vidal JE, Lomar FP, Barbas CV, de Matos GJ, Boulos M. Acute respiratory distress syndrome due to vivax malaria: case report and literature review. Braz J Infect Dis 2005; 9: 425-430.
177. Kumar S, Melzer M, Dodds P, Watson J, Ord R. P. vivax malaria complicated by shock and ARDS. Scand J Infect Dis 2007; 39: 255-256.
178. Price L, Planche T, Rayner C, Krishna S. Acute respiratory distress syndrome in Plasmodium vivax malaria: case report and review of the literature. Trans R Soc Trop Med Hyg 2007; 101: 655-659.
179. Maguire JD, Fenton ME, Susanti AI, Walker JB. Plasmodium vivax-associated acute respiratory distress syndrome after extended travel in Afghanistan. Travel Med Infect Dis 2007; 5: 301-305.
180. Gozal D. The incidence of pulmonary manifestations during Plasmodium falciparum malaria in non immune subjects. Trop Med Parasitol 1992; 43: 6-8.
181. Rajput R, Singh H, Singh S, Tiwari UC. Pulmonary manifestations in malaria. J Indian Med Assoc 2000; 98: 612-614.
182. Bruneel F, Hocqueloux L, Alberti C, et al. The clinical spectrum of severe imported falciparum malaria in the intensive care unit: report of 188 cases in adults. Am J Respir Crit Care Med 2003; 167: 684-689.
183. Cayea PD, Rubin E, Teixidor HS. Atypical pulmonary malaria. Am J Roentgenol 1981; 137: 51-55.
184. Yale SH, Adlakha A, Sebo TJ, Ryu JH. Bronchiolitis obliterans organizing pneumonia caused by Plasmodium vivax malaria. Chest 1993; 104: 1294-1296.
185. Makler MT, Palmer CJ, Ager AL. A review of practical techniques for the diagnosis of malaria. Ann Trop Med Parasitol 1998; 92: 419-433.
186. Drent M. Drug-induced pneumonia associated with hemizygote glucose-6 phosphate-dehydrogenase deficiency. Eur J Haematol 1998; 61: 218-220.
187. Udry E, Bailly F, Dusmet M, Schnyder P, Lemoine R, Fitting JW. Pulmonary toxicity with mefloquine. Eur Respir J 2001; 18: 890-892.
188. Soentjens P, Delanote M, van Gompel A. Mefloquine-induced pneumonitis. J Travel Med 2006; 13: 172-174.
189. Kemper CA. Pulmonary disease in selected protozoal infections. Semin Respir Infect 1997; 12: 113-121.
190. Boustani MR, Lepore TJ, Gelfand JA, Lazarus DS. Acute respiratory failure in patients treated for babesiosis. Am J Respir Crit Care Med 1994; 149: 1689-1691.
191. Byrd RP Jr, Roy TM. Acute respiratory distress syndrome following treatment for babesiosis. Expert Opin Pharmacother 2002; 3: 1541-1542.
192. Cunha BA, Nausheen S, Szalda D. Pulmonary complications of babesiosis: case report and literature review. Eur J Clin Microbiol Infect Dis 2007; 26: 505-508.
193. Gordon S, Cordon RA, Mazdzer EJ, Valigorsky JM, Blagg NA, Barnes SJ. Adult respiratory distress syndrome in babesiosis. Chest 1984; 86: 633-634.
194. Horowitz ML, Coletta F, Fein AM. Delayed onset adult respiratory distress syndrome in babesiosis. Chest 1994; 106: 1299-1301.
195. Dodd JD, Aquino SL, Sharma A. Babesiosis: CT and hematologic findings. J Thorac Imaging 2007; 22: 271-273.
196. Didier ES, Weiss LM. Microsporidiosis: current status. Curr Opin Infect Dis 2006; 19: 485-492.
197. Mertens RB, Didier ES, Fishbein MC, Bertucci DC, Rogers LB, Orenstein JM. Encephalitozoon cuniculi microsporidiosis: infection of the brain, heart, kidneys, trachea, adrenal glands, and urinary bladder in a patient with AIDS. Mod Pathol 1997; 10: 68-77.
198. Georges E, Rabaul C, Amiel C, et al. Enterocytozoon bieneusi multiorgan microsporidiosis in a HIV-infected patient. J Infect 1998; 36: 223-225.
199. Schwartz DA, Bryan RT, Hewan-Lowe KO, et al. Disseminated microsporidiosis (Encephalitozoon hellem) and acquired immunodeficiency syndrome. Autopsy evidence for respiratory acquisition. Arch Pathol Lab Med 1992; 116: 660-668.
200. Weber R, Kuster H, Visvesvara GS, Bryan RT, Schwartz DA, Lüthy R. Disseminated microsporidiosis due to Encephalitozoon hellem: pulmonary colonization, microhematuria, and mild conjunctivitis in a patient with AIDS. Clin Infect Dis 1993; 17: 415-419.
201. Weber R, Kuster H, Keller R, et al. Pulmonary and intestinal microsporidiosis in a patient with the acquired immunodeficiency syndrome. Am Rev Respir Dis 1992; 146: 1603-1605.
202. Schwartz DA, Visvesvara GS, Leitch GJ, et al. Pathology of symptomatic microsporidial (Encephalitozoon hellem) bronchiolitis in the
203. Remadi S, Dumais J, Wafa K, MacGee W. Pulmonary microsporidiosis in a patient with the acquired immunodeficiency syndrome. A case report. Acta Cytol 1995; 39: 1112-1116.
204. Scaglia M, Sacchi L, Croppo GP, et al. Pulmonary microsporidiosis due to Encephalitozoon hellem in a patient with AIDS. J Infect 1997; 34: 119-126.
205. Kelkar R, Sastry PS, Kulkarni SS, Saikia TK, Parikh PM, Advani SH. Pulmonary microsporidial infection in a patient with CML undergoing allogeneic marrow transplant. Bone Marrow Transplant 1997; 19: 179-182.
206. Teachey DT, Russo P, Orenstein JM, Didier ES, Bowers C, Bunin N. Pulmonary infection with microsporidia after allogeneic bone marrow transplantation. Bone Marrow Transplant 2004; 33: 299-302.
207. Orenstein JM, Russo P, Didier ES, Bowers C, Bunin N, Teachey DT. Fatal pulmonary microsporidiosis due to Encephalitozoon cuniculi following allogeneic bone marrow transplantation for acute myelogenous leukemia. Ultrastruct Pathol 2005; 29: 269-276.
208. Botterel F, Minozzi C, Vittecoq D, Bourée P. Pulmonary localization of Enterocytozoon bieneusi in an AIDS patient: Case report and review. J Clin Microbiol 2002; 40: 4800-4801.
209. Franzen C, Müller A, Salzberger B, Fätkenheuer G, Diehl V, Schrappe M. Chronic rhinosinusitis in patients with AIDS: potential role of microsporidia. AIDS 1996; 10: 687-688.
210. Didier ES, Rogers LB, Orenstein JM, et al. Characterization of Encephalitozoon (Septata) intestinalis isolates cultured from nasal mucosa and bronchoalveolar lavage fluids of two AIDS patients. J Eukaryot Microbiol 1996; 43: 34-43.
211. del Aguila C, Lopez-Velez R, Fenoy S, et al. Identification of Enterocytozoon bieneusi spores in respiratory samples from an AIDS patient with a 2-year history of intestinal microsporidiosis. J Clin Microbiol 1997; 35: 1862-1866.
212. Vasilakopoulou A, Dimarongona K, Samakovli A, Papadimitris K, Avlami A. Balantidium coli pneumonia in an immunocompromised patient. Scand J Infect Dis 2003; 35: 144-146.
213. Anargyrou K, Petrikkos GL, Suller MT, et al. Pulmonary Balantidium coli infection in a leukemic patient. Am J Hematol 2003; 73: 180-183.
214. Dorfman S, Rangel O, Bravo LG. Balantidiasis: report of a fatal case with appendicular and pulmonary involvement. Trans R Soc Trop Med Hyg 1984; 78: 833-834.
215. Sharma S, Harding G. Necrotizing lung infection caused by the protozoan Balantidium coli. Can J Infect Dis Med Microbiol 2003; 14: 163-166.
216. Ladas SD, Savva S, Frydas A, Kaloviduris A, Hatzioannou J, Raptis S. Invasive balantidiasis presented as chronic colitis and lung involvement. Dig Dis Sci 1989; 34: 1621-1623.